Why Corporate Innovation Matters: The Cost of Standing Still

Incumbency Is No Longer Protection

The average company now survives on the S&P 500 for roughly 15 to 20 years (Innosight’s Corporate Longevity Forecast, via Apollo Academy), down from about 33 in the 1960s — and at the current churn rate, roughly half the index is on track to be replaced within a decade. That is the real cost of standing still: not a bad quarter, but quiet irrelevance. Corporate innovation is the discipline of not being in the half that gets replaced. This is a top-of-the-funnel primer on why it matters, why established companies are structurally bad at it, and where to start.

What Corporate Innovation Actually Is

Corporate innovation is the deliberate work of creating new sources of value — new products, business models, or markets — alongside running the existing business. The “alongside” is the hard part. Every established company already has a machine that reliably produces revenue, and that machine consumes almost all of the attention, budget, and talent. Innovation is what you do with the small remainder to make sure the machine you have isn’t the only one you’ll ever have.

It helps to be precise about what it is not. Corporate innovation is not the R&D department shipping the next version of the current product. It is not a hackathon, an innovation lab with beanbags, or a corporate venture fund writing cheques. Those can be inputs, but on their own they are theatre. Real corporate innovation changes what the company sells, who it sells to, or how it makes money — and it survives contact with the core business’s budget cycle.

The Cost of Standing Still

“Standing still” sounds safe. It is the most dangerous thing an incumbent can do, because the ground moves underneath it. Economists call the process creative destruction; in the boardroom it shows up as a competitor, a technology, or a customer behaviour that quietly makes your advantage irrelevant.

The canonical example is Kodak. Its own engineer built the first digital camera in 1975. Kodak saw the future, patented pieces of it, and then spent 30 years protecting the film business that future would destroy — until it filed for bankruptcy in 2012. Blockbuster passed on buying Netflix around 2000 and was bankrupt by 2010. Nokia dominated mobile phones and sold the business to Microsoft in 2013. None of these companies failed because they were badly run. They failed because being well run, in the old model, is not the same as being ready for the new one.

Innovation Is Not Optimization (and Automation Isn’t Either)

This is the distinction most leadership teams blur, and it’s worth being blunt about — especially now that AI and automation make optimization so easy. Making the current business faster, cheaper, and more efficient is enormously valuable. It is also not innovation. Automation optimizes the model you already have; it does not build the one that replaces it.

Both matter, and they compete for the same budget. A useful way to hold them together is a portfolio: defend and optimize the core, extend into adjacent opportunities, and place a few deliberate bets on transformational ones. Most companies over-invest in the first, under-invest in the third, and confuse a strong optimization program — a great workflow automation rollout, say — with having an innovation strategy. Optimization keeps you alive this year. Innovation keeps you relevant in ten.

Why Good Companies Are Bad at This: The Innovator’s Dilemma

In 1997, Clayton Christensen gave the problem its name in The Innovator’s Dilemma. His uncomfortable finding: well-managed incumbents fail because they do everything business school tells them to. They listen to their best, most profitable customers. They invest in improvements those customers ask for. And they rationally decline to chase small, low-margin, initially-inferior markets — which is exactly where disruptive technologies start before they grow up and take everything.

Every large organisation also grows antibodies. New ideas threaten existing revenue, existing power structures, and existing careers, so the organisation kills them — not out of malice, but out of a healthy instinct to protect what works. The result is that the very competence that makes a company good at its current business makes it bad at inventing its next one. Innovation isn’t hard for incumbents because they lack smart people. It’s hard because the system is optimised to reject it.

Everyone Agrees It Matters. Almost Nobody Is Ready.

If corporate innovation is so clearly existential, why is it so rare? Because agreeing with it is free and doing it is expensive. The gap between the two is stark and well-documented.

McKinsey found that 84% of executives consider innovation essential to their growth strategy, while just 6% are satisfied with how they actually do it. BCG’s 2024 data tells the same story from the other side: 83% call it a top-three priority, but only 3% feel ready to execute. The belief is nearly universal. The readiness is nearly absent. That gap — not a lack of conviction — is where incumbents lose.

Where to Start

The mistake is to treat corporate innovation as a giant transformation program you announce at an offsite. That triggers every organisational antibody at once. The better first move is small, cheap, and diagnostic: figure out how you would lose before you decide what to build.

The most effective tool we’ve found for that is a structured pre-mortem — assume the business has already been made irrelevant, then work backward to explain why. It surfaces the threats your team already senses but doesn’t say out loud, and, run well, it turns each of those threats into an opportunity area. If you want the step-by-step, our pre-mortem workshop playbook walks through the exact two-workshop format we use. From there, the work becomes turning the most promising of those opportunity areas into fundable bets — the job of a focused opportunity sprint.

Frequently Asked Questions

What is corporate innovation?

Corporate innovation is the deliberate practice of creating new sources of value — new products, business models, or markets — while continuing to run the existing business. It differs from ordinary R&D, which improves the current product, because it changes what the company sells, who it sells to, or how it makes money.

Why does corporate innovation matter?

Because incumbency is no longer protection. The average tenure of a company on the S&P 500 has fallen from about 33 years in the 1960s to roughly 15–20 today, and about half the index is on track to be replaced within a decade. Companies that only optimize their current model get displaced by ones that build the next one.

Isn’t innovation the same as improving efficiency or automating?

No. Efficiency and automation optimize the business model you already have — they make it cheaper and faster to run. Innovation builds the model that will replace it. Both are valuable and both compete for the same budget, but you cannot cost-cut or automate your way to a new source of growth.

Why do big, well-run companies struggle to innovate?

Because being well run in the current model actively works against it. As Clayton Christensen described in The Innovator’s Dilemma, incumbents listen to their best customers and protect their best margins, which makes them rationally ignore small, low-margin, disruptive threats until it’s too late. Large organisations also develop “antibodies” that reject ideas threatening existing revenue and power.

How does a mid-market company start with corporate innovation?

Start small and diagnostic, not with a grand transformation program. Run a structured pre-mortem to surface how you could be disrupted, reframe those threats as opportunity areas, then qualify the most promising ones into fundable bets. It’s cheaper and less politically explosive than launching an innovation lab, and it produces a real shortlist instead of a slogan.

Sources: Innosight / Apollo Academy: S&P 500 Corporate Longevity, McKinsey: The Eight Essentials of Innovation, BCG: Most Innovative Companies 2024, Forbes: How Kodak Failed